Latest Breaking News On - Jim fairbairn - Page 4 : comparemela.com

FTSE 100 Closes Down 1 1% on Middle East Tensions

The FTSE 100 closed Wednesday down 1.1% to 7588 points, with global market sentiment dampened due to rising tensions in the Middle East, CMC Markets U.K. chief market analyst Michael Hewson said in.

Marshall islandsTaylor wimpeyMichael hewsonMichael toonJim fairbairnRedx pharmaStephen harrisMelanie rossAukett swanke groupBodycote appoints jim fairbairn groupAbingdon healthTr control solutionsComptoir groupFreeline therapeutics holdingsTown centre securitiesMln buyback program

MARKET REPORT: Airlines shares fall again amid fears over the fallout from the hospital blast in Gaza

Shares in Easyjet, Wizz Air and British Airways owner IAG have fallen sharply in the wake of the attack by terrorist group Hamas on Israel this month.

Marshall islandsIsrael generalUnited kingdomJim fairbairnBritish airwaysSterling groupMegger groupWizz airPeel huntPremier innJet eastWest star aviation

XORTX Appoints Chief Financial Officer | IT Business Net

XORTX Appoints Chief Financial Officer | IT Business Net
itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.

James fairbairnJim fairbairnAllen davidoffDavid melamedAmar keshriNick rigopulosVenture exchangeTherapeutics incChief financial officerInterim chief financial officerChartered professional accountant

XORTX Appoints Chief Financial Officer

XORTX Appoints Chief Financial Officer
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Nick rigopulosJim fairbairnJames fairbairnAmar keshriAllen davidoffDavid melamedVenture exchangeTherapeutics incChief financial officerInterim chief financial officerChartered professional accountantLooking statementsthis

XORTX Appoints Chief Financial Officer

CALGARY, Alberta, Aug. 04, 2023 (GLOBE NEWSWIRE) XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late-stage clinical pharmaceutical company focused on

James fairbairnNick rigopulosJim fairbairnAmar keshriAllen davidoffDavid melamedTherapeutics incChief financial officerInterim chief financial officerChartered professional accountant